Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaniqa plus laser versus laser alone for female facial hirsutism
2006-002833-19Phase 4Terminated
- Sponsor
- Takeda
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of eflornithine in hirsutism (2 arms), sponsored by Takeda. Primary endpoint: Cumulative upper-lip hair length. Started Oct 2006; status: terminated.
02
Drugs
eflornithine
03
Conditions
hirsutism
Beyond the preview
Go deeper on 2006-002833-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002833-19.